| Ranked [title] Word list | Historiographs | Help Glossary HistCite Guide About |
| Nodes: 2913, Authors: 7350, Journals: 871, Outer References: 80285, Words: 5113
Yearly output | Document Type | Language | Institution | Institution with Subdivision | Country |
| View: Overview | Sorted by number of publications (Pubs). |
| # | Word | Pubs | TLCS | TGCS |
|---|---|---|---|---|
| 201 | CHANGES | 17 | 35 | 391 |
| 202 | CONDOM | 17 | 17 | 398 |
| 203 | DATA | 17 | 36 | 397 |
| 204 | FACTORS | 17 | 18 | 234 |
| 205 | INFECTIONS | 17 | 68 | 415 |
| 206 | LESSONS | 17 | 13 | 212 |
| 207 | LOW | 17 | 204 | 334 |
| 208 | OUTCOME | 17 | 64 | 503 |
| 209 | PORCINE | 17 | 61 | 669 |
| 210 | QUALITY-OF-LIFE | 17 | 96 | 904 |
| 211 | RELATED | 17 | 37 | 226 |
| 212 | RISKS | 17 | 71 | 498 |
| 213 | STANDARD | 17 | 54 | 333 |
| 214 | USERS | 17 | 3 | 174 |
| 215 | ADVERSE | 16 | 80 | 216 |
| 216 | CHALLENGE | 16 | 69 | 313 |
| 217 | DIFFERENTIAL | 16 | 80 | 434 |
| 218 | DUODENAL-ULCER | 16 | 24 | 271 |
| 219 | ETHICAL | 16 | 17 | 137 |
| 220 | HIV-INFECTED | 16 | 61 | 185 |
| 221 | HIV-INFECTION | 16 | 19 | 332 |
| 222 | IMPROVED | 16 | 16 | 248 |
| 223 | INTERVENTIONS | 16 | 45 | 1013 |
| 224 | PEDIATRIC | 16 | 12 | 81 |
| 225 | PROGRESS | 16 | 73 | 541 |
| 226 | PROSPECTIVE | 16 | 42 | 370 |
| 227 | PROTEINS | 16 | 70 | 380 |
| 228 | RADIOLOGY | 16 | 18 | 185 |
| 229 | RECENT | 16 | 51 | 161 |
| 230 | ROUTINE | 16 | 47 | 366 |
| # | Word | Pubs | TLCS | TGCS |
| 231 | SEXUAL | 16 | 19 | 558 |
| 232 | TYPE | 16 | 23 | 252 |
| 233 | BODY | 15 | 162 | 300 |
| 234 | CHANGING | 15 | 60 | 1070 |
| 235 | CONSIDERATIONS | 15 | 118 | 205 |
| 236 | EXPRESSION | 15 | 84 | 393 |
| 237 | IMMUNOGENICITY | 15 | 77 | 312 |
| 238 | INFARCTION | 15 | 14 | 213 |
| 239 | MEN | 15 | 19 | 304 |
| 240 | METHOD | 15 | 24 | 413 |
| 241 | NEONATAL | 15 | 51 | 236 |
| 242 | PREVENTIVE | 15 | 7 | 200 |
| 243 | SURGICAL | 15 | 9 | 86 |
| 244 | SURVIVAL | 15 | 14 | 285 |
| 245 | TEACHING | 15 | 10 | 140 |
| 246 | TRADE-OFF | 15 | 53 | 304 |
| 247 | WORKERS | 15 | 29 | 212 |
| 248 | ADULT | 14 | 5 | 266 |
| 249 | AGE | 14 | 14 | 178 |
| 250 | APPROACHES | 14 | 25 | 206 |
| 251 | BENEFITS | 14 | 30 | 381 |
| 252 | COMMUNITY | 14 | 21 | 157 |
| 253 | COUNTRIES | 14 | 38 | 195 |
| 254 | CRITICAL | 14 | 23 | 452 |
| 255 | DECISION-ANALYSIS | 14 | 60 | 496 |
| 256 | DESIGN | 14 | 22 | 146 |
| 257 | DRUGS | 14 | 27 | 813 |
| 258 | ENDOGENOUS | 14 | 60 | 516 |
| 259 | EXPRESSING | 14 | 139 | 530 |
| 260 | HEALTH-RELATED | 14 | 35 | 387 |
| # | Word | Pubs | TLCS | TGCS |
| 261 | INDIVIDUAL | 14 | 125 | 322 |
| 262 | OLD | 14 | 2 | 57 |
| 263 | PEPTIC | 14 | 2 | 243 |
| 264 | PHYSICIAN | 14 | 42 | 513 |
| 265 | PUBLIC-HEALTH | 14 | 189 | 390 |
| 266 | RADIATION-THERAPY | 14 | 111 | 255 |
| 267 | RAPID | 14 | 28 | 819 |
| 268 | SERVICES | 14 | 20 | 380 |
| 269 | SOCIAL | 14 | 44 | 215 |
| 270 | STUDENTS | 14 | 11 | 64 |
| 271 | THROMBOLYTIC | 14 | 38 | 969 |
| 272 | ANALYSES | 13 | 13 | 300 |
| 273 | APPLICATION | 13 | 45 | 240 |
| 274 | BACTERIAL | 13 | 49 | 275 |
| 275 | BONE | 13 | 17 | 386 |
| 276 | EFFECTIVE | 13 | 14 | 136 |
| 277 | ETHICS | 13 | 4 | 141 |
| 278 | GROUP | 13 | 28 | 290 |
| 279 | IDENTIFICATION | 13 | 19 | 245 |
| 280 | IMPROVING | 13 | 8 | 172 |
| 281 | INFANTS | 13 | 147 | 203 |
| 282 | INFECTED | 13 | 26 | 294 |
| 283 | METHODOLOGICAL | 13 | 33 | 556 |
| 284 | MULTIDRUG-RESISTANT | 13 | 31 | 130 |
| 285 | MYCOBACTERIA | 13 | 81 | 250 |
| 286 | OVERVIEW | 13 | 8 | 151 |
| 287 | PATTERNS | 13 | 32 | 408 |
| 288 | PERFORMANCE | 13 | 22 | 175 |
| 289 | PERSPECTIVE | 13 | 10 | 148 |
| 290 | PREVALENCE | 13 | 53 | 185 |
| # | Word | Pubs | TLCS | TGCS |
| 291 | RELATIONSHIP | 13 | 107 | 417 |
| 292 | SKIN | 13 | 17 | 102 |
| 293 | STOOL | 13 | 81 | 175 |
| 294 | TECHNIQUES | 13 | 25 | 131 |
| 295 | UNDERSTANDING | 13 | 14 | 250 |
| 296 | UNITED | 13 | 3 | 39 |
| 297 | VALUES | 13 | 34 | 210 |
| 298 | ABDOMINAL | 12 | 2 | 233 |
| 299 | ASPECTS | 12 | 2 | 38 |
| 300 | CHALLENGES | 12 | 9 | 90 |
| 301 | COHORT | 12 | 18 | 115 |
| 302 | COUNSELING | 12 | 9 | 218 |
| 303 | GASTRIC | 12 | 19 | 149 |
| 304 | HIGH | 12 | 94 | 233 |
| 305 | IMPROVE | 12 | 4 | 697 |
| 306 | ISCHEMIA | 12 | 56 | 636 |
| 307 | LONG-TERM | 12 | 16 | 324 |
| 308 | MOLECULAR | 12 | 82 | 585 |
| 309 | NEEDS | 12 | 24 | 90 |
| 310 | PERSONS | 12 | 8 | 200 |
| 311 | POPULATIONS | 12 | 11 | 85 |
| 312 | RATES | 12 | 15 | 358 |
| 313 | STRATEGY | 12 | 8 | 99 |
| 314 | WORLD | 12 | 1 | 23 |
| 315 | ACELLULAR | 11 | 7 | 55 |
| 316 | ARTHRITIS | 11 | 44 | 162 |
| 317 | CARDIOVASCULAR | 11 | 38 | 352 |
| 318 | CHARACTERISTICS | 11 | 61 | 690 |
| 319 | CLINICAL-TRIALS | 11 | 73 | 656 |
| 320 | CLONING | 11 | 48 | 168 |
| # | Word | Pubs | TLCS | TGCS |
| 321 | CORONARY-ARTERY | 11 | 26 | 225 |
| 322 | DEATH | 11 | 27 | 271 |
| 323 | DETECTION | 11 | 3 | 76 |
| 324 | DEVELOPING | 11 | 7 | 99 |
| 325 | DIFFERENCES | 11 | 49 | 589 |
| 326 | ECONOMICS | 11 | 15 | 125 |
| 327 | EVENTS | 11 | 72 | 155 |
| 328 | FOLLOWING | 11 | 68 | 125 |
| 329 | FRAMEWORK | 11 | 42 | 269 |
| 330 | GAMMA | 11 | 28 | 218 |
| 331 | GENE | 11 | 38 | 176 |
| 332 | HEPATITIS | 11 | 8 | 262 |
| 333 | HISTORY | 11 | 13 | 179 |
| 334 | MODELING | 11 | 54 | 202 |
| 335 | ORGANIZATION | 11 | 25 | 325 |
| 336 | PERSPECTIVES | 11 | 7 | 65 |
| 337 | TISSUE | 11 | 43 | 263 |
| 338 | TRAINING | 11 | 18 | 154 |
| 339 | TRAVELERS | 11 | 53 | 103 |
| 340 | UNITS | 11 | 24 | 209 |
| 341 | VACCINATIONS | 11 | 2 | 108 |
| 342 | YEAR | 11 | 15 | 446 |
| 343 | AGENTS | 10 | 12 | 200 |
| 344 | ASSOCIATION | 10 | 13 | 150 |
| 345 | BLOOD | 10 | 11 | 153 |
| 346 | CANADA | 10 | 4 | 55 |
| 347 | COMPUTERIZED | 10 | 137 | 218 |
| 348 | COST-UTILITY | 10 | 13 | 117 |
| 349 | CULTURES | 10 | 81 | 191 |
| 350 | DELIVERY | 10 | 10 | 105 |
| # | Word | Pubs | TLCS | TGCS |
| 351 | DIABETES | 10 | 7 | 74 |
| 352 | ECHOCARDIOGRAPHY | 10 | 9 | 85 |
| 353 | EXAMINATION | 10 | 4 | 218 |
| 354 | EXERCISE | 10 | 7 | 190 |
| 355 | EXPERIMENTAL | 10 | 23 | 101 |
| 356 | FRANCE | 10 | 1 | 8 |
| 357 | GROWTH | 10 | 19 | 183 |
| 358 | IMMUNIZATIONS | 10 | 4 | 74 |
| 359 | INDUCED | 10 | 64 | 200 |
| 360 | INDUCES | 10 | 17 | 73 |
| 361 | INTERMEDIATE | 10 | 17 | 179 |
| 362 | INTERNATIONAL | 10 | 2 | 48 |
| 363 | MAGNETIC | 10 | 27 | 121 |
| 364 | PIG | 10 | 52 | 265 |
| 365 | POSSIBLE | 10 | 21 | 202 |
| 366 | PREVENTING | 10 | 69 | 217 |
| 367 | PROGRAMS | 10 | 41 | 206 |
| 368 | PROSPECTS | 10 | 172 | 327 |
| 369 | PROSTATE | 10 | 12 | 140 |
| 370 | RESONANCE | 10 | 27 | 121 |
| 371 | RETROVIRUS | 10 | 55 | 448 |
| 372 | SECRETED | 10 | 83 | 435 |
| 373 | SEX | 10 | 16 | 218 |
| 374 | SPECIFIC | 10 | 16 | 156 |
| 375 | TRIAGE | 10 | 59 | 822 |
| 376 | UPDATE | 10 | 7 | 197 |
| 377 | VARIATION | 10 | 137 | 586 |
| 378 | AFRICA | 9 | 6 | 81 |
| 379 | AMERICAN | 9 | 20 | 105 |
| 380 | ATTENUATED | 9 | 33 | 166 |
| # | Word | Pubs | TLCS | TGCS |
| 381 | CALMETTE | 9 | 27 | 160 |
| 382 | CAT | 9 | 54 | 200 |
| 383 | CHARACTERIZATION | 9 | 44 | 357 |
| 384 | COMPLEX | 9 | 22 | 93 |
| 385 | COMPUTERIZED-TOMOGRAPHY | 9 | 13 | 201 |
| 386 | COST-EFFECTIVE | 9 | 21 | 113 |
| 387 | CRITERIA | 9 | 18 | 89 |
| 388 | DELTA | 9 | 36 | 246 |
| 389 | DEVELOPMENTS | 9 | 4 | 82 |
| 390 | DIAGNOSTIC-TESTS | 9 | 31 | 657 |
| 391 | DIFFERENT | 9 | 65 | 237 |
| 392 | ELDERLY | 9 | 0 | 149 |
| 393 | EVALUATIONS | 9 | 39 | 772 |
| 394 | EVIDENCE-BASED | 9 | 11 | 163 |
| 395 | FAILURE | 9 | 54 | 195 |
| 396 | FINDINGS | 9 | 93 | 312 |
| 397 | FRENCH | 9 | 13 | 164 |
| 398 | GAMBLE | 9 | 33 | 159 |
| 399 | GENETIC | 9 | 44 | 490 |
| 400 | GUINEA | 9 | 28 | 83 |
Page 2 of 26: [ 1 2 3 4 5 6 7 8 9 10 ] 11 21